BERNSTEIN HAROLD (President, R&D & CMO) sold 4.84K shares of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $195.7K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/6/2026ACC: 0002050172-26-000003
Officer· President, R&D & CMO
Since Mar 2026
-4.84K
Net shares
Net seller
$195.7K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
4.84K acquired · 9.69K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+4.43K
Price / share
$10.42
Trade value
$46.18K
% of position
New position
1/2/2026
0.00→4.43K
Common Stock
Direct
Shares
−4.43K
Price / share
$40.43
Trade value
$179.19K
% of position
New position
1/2/2026
4.43K→0.00
Common Stock
Direct
Shares
+412.00
Price / share
$10.42
Trade value
$4.29K
% of position
New position
1/5/2026
0.00→412.00
Common Stock
Direct
Shares
−412.00
Price / share
$40.00
Trade value
$16.48K
% of position
New position
1/5/2026
412.00→0.00
Total
Net shares
+0.00
Net value
-$145.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | M · Option Exercise | +4.43K | $10.42 | $46.18K | New position | 0.00 | 4.43K |
| Common Stock Direct | 1/2/2026 | S · Sale | −4.43K | $40.43 | $179.19K | New position | 4.43K | 0.00 |
| Common Stock Direct | 1/5/2026 | M · Option Exercise | +412.00 | $10.42 | $4.29K | New position | 0.00 | 412.00 |
| Common Stock Direct | 1/5/2026 | S · Sale | −412.00 | $40.00 | $16.48K | New position | 412.00 | 0.00 |
| Total | +0.00 | -$145.19K | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
4.43K shares
Shares
−4.43K
Strike price
10.42
Held after
337.98K
Exercisable
—
1/2/2026
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
412.00 shares
Shares
−412.00
Strike price
10.42
Held after
337.56K
Exercisable
—
1/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock4.43K shares | 1/2/2026 | M · Option Exercise | −4.43K | 10.42 | — | 337.98K |
| Stock Option (Right to Buy) Direct | Common Stock412.00 shares | 1/5/2026 | M · Option Exercise | −412.00 | 10.42 | — | 337.56K |